doi: 10.1016/0090-1229(89)90222-5.
Prophylaxis and treatment of pneumococcal bacteremia by immune globulin intravenous in a mouse model
Affiliations
- PMID: 2491979
- DOI: 10.1016/0090-1229(89)90222-5
Item in Clipboard
Prophylaxis and treatment of pneumococcal bacteremia by immune globulin intravenous in a mouse model
Clin Immunol Immunopathol.
1989 Jan.
Abstract
A mouse model was developed to test the efficacy of human immune globulin intravenous (IGIV) in prevention and treatment of pneumococcal bacteremia. Mice pretreated with IGIV and then challenged with types 3 or 7F Streptococcus pneumoniae had significantly increased (P less than 0.025) survival compared to controls. Three commercially available IGIV preparations were all effective in significantly increasing (P less than 0.025) survival in mice already infected. Mice treated with IGIV plus penicillin had significantly greater (P less than 0.05) survival than those who received penicillin alone. IGIV may be useful in treatment of pneumococcal bacteremia.
Similar articles
-
Prevention of pneumococcal bacteremia in a child with acquired immunodeficiency syndrome-related complex.Pediatr Infect Dis J. 1987 Jun;6(6):564-6. doi: 10.1097/00006454-198706000-00015. Pediatr Infect Dis J. 1987. PMID: 3112723 No abstract available.
-
Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparations.Clin Diagn Lab Immunol. 2004 Nov;11(6):1158-64. doi: 10.1128/CDLI.11.6.1158-1164.2004. Clin Diagn Lab Immunol. 2004. PMID: 15539522 Free PMC article.
-
Use of a new, low-pH immunoglobulin G preparation during episodes of bacteremia in the rat.Rev Infect Dis. 1986 Jul-Aug;8 Suppl 4:S409-19. doi: 10.1093/clinids/8.supplement_4.s409. Rev Infect Dis. 1986. PMID: 3092308
-
Supplemental immune globulins in sepsis.Clin Chem Lab Med. 1999 Mar;37(3):341-9. doi: 10.1515/CCLM.1999.057. Clin Chem Lab Med. 1999. PMID: 10353481 Review.
-
Pneumococcal bacteremia. Review of 111 cases, 1957--1969, with special reference to cases with undetermined focus.Am J Dis Child. 1971 Apr;121(4):353-9. Am J Dis Child. 1971. PMID: 4396753 Review. No abstract available.
Cited by
-
Evaluation of a novel therapeutic approach to treating severe pneumococcal infection using a mouse model.Clin Vaccine Immunol. 2009 Jun;16(6):806-10. doi: 10.1128/CVI.00120-09. Epub 2009 Apr 22. Clin Vaccine Immunol. 2009. PMID: 19386795 Free PMC article.
-
Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.Antonie Van Leeuwenhoek. 1990 Jun;58(1):1-47. doi: 10.1007/BF02388078. Antonie Van Leeuwenhoek. 1990. PMID: 2195989 Review. No abstract available.
-
Immunotherapy with a combination of intravenous immune globulin and p4 peptide rescues mice from postinfluenza pneumococcal pneumonia.Antimicrob Agents Chemother. 2011 May;55(5):2276-81. doi: 10.1128/AAC.00057-11. Epub 2011 Mar 7. Antimicrob Agents Chemother. 2011. PMID: 21383090 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical